Cutter Capital Management, LP Arcellx, Inc. Transaction History
Cutter Capital Management, LP
- $331 Billion
- Q2 2024
A detailed history of Cutter Capital Management, LP transactions in Arcellx, Inc. stock. As of the latest transaction made, Cutter Capital Management, LP holds 187,000 shares of ACLX stock, worth $15.9 Million. This represents 3.12% of its overall portfolio holdings.
Number of Shares
187,000
Previous 107,000
74.77%
Holding current value
$15.9 Million
Previous $7.44 Billion
38.68%
% of portfolio
3.12%
Previous 2.85%
Shares
2 transactions
Others Institutions Holding ACLX
# of Institutions
173Shares Held
45.6MCall Options Held
53.6KPut Options Held
53.7K-
Perceptive Advisors LLC New York, NY3.89MShares$330 Million6.21% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY3.85MShares$327 Million8.59% of portfolio
-
Nea Management Company, LLC Timonium, MD3.75MShares$318 Million19.51% of portfolio
-
Black Rock Inc. New York, NY3.52MShares$299 Million0.0% of portfolio
-
Sr One Capital Management, LP2.35MShares$199 Million56.87% of portfolio
About Arcellx, Inc.
- Ticker ACLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,819,200
- Market Cap $3.72B
- Description
- Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It...